-
Symbol
-
CRSP on Nasdaq
-
Investment type
-
Equity / Common Stock
-
Latest Disclosed Shares Owned
-
5,934,328 shares
-
Security Ownership %
-
6.2%
ORBIS INVESTMENT MANAGEMENT LTD ownership in CRISPR Therapeutics AG Common Stock (CRSP)
17 Feb 2026 - ORBIS INVESTMENT MANAGEMENT LTD has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,934,328 shares of CRISPR Therapeutics AG Common Stock (CRSP).
This represents 6.2% ownership of the company.
In their previous filing dated 14 Nov 2025, ORBIS INVESTMENT MANAGEMENT LTD had reported owning 4,974,125 shares, indicating an increase of +19%.
.